Enalapril: new possibilities

Enalapril: new possibilities

The review presents the modern evidence on new properties of enalapril, which widens our perception of therapeutic effects of this medication.

Bibliographic Details
Main Author:	E. O. Taratukhin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2012-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	артериальная гипертензия сердечная недостаточность ангиотензин-превращающий фермент
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1922

Similar Items

ACE gene ID polymorphism in acute coronary syndrome patients
by: R. T. Saygitov, et al.
Published: (1970-01-01)

Variation of Concentrations of Angiotensin II, AngiotensinConverting Enzyme and Matrix Metalloprotease-9 in Tears and Serum of Patients with Diabetic Retinopathy
by: V. V. Neroev, et al.
Published: (2020-12-01)

MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
by: E. I. Astashkin, et al.
Published: (2013-06-01)

Arterial hypertension as a heart failure predictor in patients with chronic glomerulonephritis and intact renal function
by: N. Yu. Borovkova, et al.
Published: (2009-10-01)

Chronic heart failure in out-patient practice: aetiology issues
by: S. M. Bogdanova, et al.
Published: (2008-08-01)

SELECTION OF THE OPTIMAL ANTIHYPERTENSION TREATMENT IN PATIENTS WITH CHRONIC HEART FAILURE WITH THE SIGNS OF CHRONIC KIDNEY DISEASE
by: N. Yu Borovkova, et al.
Published: (2016-12-01)

Natriuretic peptides: new challenges — new solutions
by: O. M. Drapkina, et al.
Published: (2021-11-01)

Personal Characteristics and Adaptation Mechanisms of Patients with Arterial Hypertension and Chronic Heart Failure
by: E. V. Efremova, et al.
Published: (2021-01-01)

Blokatory beta-adrenergicheskikh retseptorov v lechenii arterial'noy gipertenzii u bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu
by: D V Preobrazhenskiy, et al.
Published: (2006-03-01)

Adherence to therapy, lifestyle modification and medical support of cardiovascular patients
by: S. S. Bunova, et al.
Published: (2020-12-01)

Nitrate place in modern cardiology
by: D. A. Zateyshchikov, et al.
Published: (2007-04-01)

SECONDARY PHARMACOLOGICAL PREVENTION OF CARDIOVASCULAR DISEASES: OUR ABILITY IN CLINICAL PRACTICE
by: E. V. Filippov, et al.
Published: (2015-12-01)

ГИПЕРТРОФИЧЕСКАЯ КАРДИОМИОПАТИЯ И СОЧЕТАННАЯ КАРДИОЛОГИЧЕСКАЯ ПАТОЛОГИЯ : ОСОБЕННОСТИ ДИАГНОСТИКИ И ЛЕЧЕНИЯ
by: С. С. Якушин, et al.
Published: (2011-02-01)

ЭПИДЕМИОЛОГИЧЕСКИЕ ОСОБЕННОСТИ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Е. Г. Артемьева, et al.
Published: (2014-02-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01)

Ингибитор фосфодиэстеразы-5 в лечении легочной артериальной гипертензии
Published: (2019-09-01)

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors
by: R. D. Smith, et al.
Published: (2010-12-01)

Levels of cytokines and C-reactive protein as treatment effectiveness criteria in patients with coronary heart disease and chronic heart failure
by: E. Yu. Sazhina, et al.
Published: (2008-06-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Protivoishemicheskoe, antiaritmicheskoe i sosudistoe deystvie ingibitora angiotenzinprevrashchayushchego fermenta zofenoprila v eksperimente
by: E V Shlyakhto, et al.
Published: (2006-06-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease
by: C. Napoli
Published: (2011-12-01)

ВЛИЯНИЕ МЕТАБОЛИЧЕСКОЙ ХИРУРГИИ НА ТЕЧЕНИЕ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ
by: Олег Викторович Корнюшин, et al.
Published: (2022-01-01)

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

Hypertensive encephalopathy, heart remodeling, and chronic heart failure
by: L. A. Geraskina, et al.
Published: (2006-06-01)

Vitamin D role in arterial hypertension development
by: E. N. Dudinskaya, et al.
Published: (2012-06-01)

Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place
by: L. I. Olbinskaya, et al.
Published: (2007-02-01)

Selection of an ACE inhibitor in clinical practice
by: OD Ostroumova, et al.
Published: (2014-12-01)

Epidemiological aspects of nephrolithiasis and chronic diseases of the cardiovascular system combination
by: R. V. Royuk, et al.
Published: (2020-03-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

Effects of the fixed-dose combination therapy with indapamide and valsartan on renal function in patients with Type 2 diabetes mellitus and arterial hypertension
by: T. V. Malykh, et al.
Published: (2011-12-01)

Comparative effectiveness of perindopril and enalapril in patients with arterial hypertension and obesity
by: S. V. Nedogoda, et al.
Published: (1970-01-01)

Indapamide retard in complex therapy of patients with chronic heart failure and arterial hypertension
by: S. N. Tereshchenko, et al.
Published: (2010-04-01)

COMPARATIVE EFFECTIVENESS OF FIXED-DOSE COMBINATIONS OF LISINOPRIL/AMLODIPINE AND ENALAPRIL/HYDROCHLOROTHIAZIDE
by: S. V. Nedogoda, et al.
Published: (2013-04-01)

ВЛИЯНИЕ КОМБИНИРОВАННОЙ ТЕРАПИИ НА ЦЕНТРАЛЬНОЕ АРТЕРИАЛЬНОЕ ДАВЛЕНИЕ И АРТЕРИАЛЬНУЮ РИГИДНОСТЬ
Published: (2016-12-01)

Probiotics, metabolism and the functional condition of cardio-vascular system
by: Ye. A. Kashukh, et al.
Published: (2016-08-01)

Патогенез артериальной гипертензии (Лекция)
by: Дмитрий Игоревич Василевский, et al.
Published: (2020-12-01)

Renin-angiotensin system blockers: therapy of choice in patients with arterial hypertension and heart failure
by: G. N. Gorokhovskaya, et al.
Published: (2013-12-01)

Anti-inflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation
by: Danilo Fliser, et al.
Published: (1970-01-01)

ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE
by: M. V. Surovtseva, et al.
Published: (2015-12-01)